133 related articles for article (PubMed ID: 32111782)
1. Interval Between Cancer Diagnosis and Radiotherapy - An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer.
Rades D; Haus R; Janssen S; Schild SE
In Vivo; 2020; 34(2):767-770. PubMed ID: 32111782
[TBL] [Abstract][Full Text] [Related]
2. Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer.
Haus R; Janssen S; Schild SE; Rades D
In Vivo; 2020; 34(2):679-682. PubMed ID: 32111769
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases.
Rades D; Haus R; Schild SE; Janssen S
BMC Cancer; 2019 Nov; 19(1):1156. PubMed ID: 31779595
[TBL] [Abstract][Full Text] [Related]
5. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
[TBL] [Abstract][Full Text] [Related]
6. [Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients].
Koswig S; Buchali A; Böhmer D; Schlenger L; Budach V
Strahlenther Onkol; 1999 Oct; 175(10):509-14. PubMed ID: 10554646
[TBL] [Abstract][Full Text] [Related]
7. A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer.
Haus R; Janssen S; Schild SE; Rades D
Anticancer Res; 2020 Jan; 40(1):287-291. PubMed ID: 31892578
[TBL] [Abstract][Full Text] [Related]
8. A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases.
Janssen S; Haus R; Schild SE; Rades D
Anticancer Res; 2020 Jan; 40(1):367-371. PubMed ID: 31892588
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases.
Ratasvuori M; Wedin R; Hansen BH; Keller J; Trovik C; Zaikova O; Bergh P; Kalen A; Laitinen M
J Surg Oncol; 2014 Sep; 110(4):360-5. PubMed ID: 24889389
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
[TBL] [Abstract][Full Text] [Related]
14. The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma.
Wilson D; Hiller L; Gray L; Grainger M; Stirling A; James N
Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):400-7. PubMed ID: 14570088
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases.
Peng B; Yang C; He J
J Transl Med; 2016 Apr; 14():102. PubMed ID: 27116938
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy of bone metastases in France: A descriptive monocentric retrospective study].
Le Fèvre C; Antoni D; Thiéry A; Keller A; Truntzer P; Vigneron C; Clavier JB; Guihard S; Pop M; Schumacher C; Salze P; Noël G
Cancer Radiother; 2018 Apr; 22(2):148-162. PubMed ID: 29602695
[TBL] [Abstract][Full Text] [Related]
18. [Clinical results and prognostic factors of radiotherapy for bone metastases from breast cancer].
Yoden E; Murakami M; Kuroda Y; Kono K; Sasaki R
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jan; 59(1):27-33. PubMed ID: 10067313
[TBL] [Abstract][Full Text] [Related]
19. Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer.
Rades D; Bolm L; Schild SE; Bartscht T
Anticancer Res; 2017 Jan; 37(1):203-206. PubMed ID: 28011492
[TBL] [Abstract][Full Text] [Related]
20. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
